Invention Grant
- Patent Title: GP120 immunogens and methods inducing neutralizing antibodies to human immunodeficiency virus
-
Application No.: US14349539Application Date: 2012-10-03
-
Publication No.: US10092638B2Publication Date: 2018-10-09
- Inventor: Barton F. Haynes , Garnett Kelsoe , Stephen Harrison , Thomas B. Kepler
- Applicant: DUKE UNIVERSITY , Children's Medical Center Corporation
- Applicant Address: US NC Durham US MA Boston
- Assignee: DUKE UNIVERSITY,CHILDREN'S MEDICAL CENTER CORPORATION
- Current Assignee: DUKE UNIVERSITY,CHILDREN'S MEDICAL CENTER CORPORATION
- Current Assignee Address: US NC Durham US MA Boston
- Agency: Wilmer Cutler Pickering Hale and Dorr LLP
- International Application: PCT/US2012/000442 WO 20121003
- International Announcement: WO2013/052095 WO 20130411
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K39/21 ; C07K16/10 ; C12N7/00 ; G06F19/12 ; A61K39/00
Abstract:
The present invention relates, in general, to an HIV-1 vaccine and, in particular, to a B cell lineage-based vaccination protocol.
Public/Granted literature
- US20140341949A1 VACCINE Public/Granted day:2014-11-20
Information query
